MKMoe Kyaw Kyaw

Moe Kyaw Kyaw

*This is an algorithmically generated author record based on publicly available information.

Moe Kyaw Kyaw has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Entomological determinants of insecticide-treated bed net effectiveness in Western Myanmar

    by Frank M Smithuis, Moe Kyaw Kyaw, U Ohn Phe, Ingrid van der Broek, Nina Katterman, Colin Rogers, Patrick Almeida, Piet A Kager, Kasia Stepniewska, Yoel Lubell, et al.

    In a large cluster randomized control trial of insecticide-treated bed nets (ITN) in Western Myanmar the malaria protective effect of ITN was found to be highly variable and, in aggregate, the effect was not statistically significant. A coincident entomological investigation measured malaria vector abundance and biting behaviour and the human population sleeping habits, factors relevant to ITN effectiveness.


  • Open Access

    The effect of insecticide-treated bed nets on the incidence and prevalence of malaria in children in an area of unstable seasonal transmission in western Myanmar

    by Frank M Smithuis, Moe Kyaw Kyaw, U Ohn Phe, Ingrid van der Broek, Nina Katterman, Colin Rogers, Patrick Almeida, Piet A Kager, Kasia Stepniewska, Yoel Lubell, et al.

    Background: Insecticide-treated bed nets (ITN) reduce malaria morbidity and mortality consistently in Africa, but their benefits have been less consistent in Asia. This study’s objective was to evaluate the malaria protective efficacy of village-wide usage of ITN in Western Myanmar and estimate the cost-effectiveness of ITN compared with extending early diagnosis and treatment services. Methods: A cluster-randomized controlled trial was conducted in Rakhine State to assess the efficacy of ITNs in preventing malaria and anaemia in children and their secondary effects on nutrition and development. The data were aggregated for each village to obtain cluster-level infection rates. In total 8,175 children under 10 years of age were followed up for 10 months, which included the main malaria transmission period. The incidence and prevalence of Plasmodium falciparum and Plasmodium vivax infections, and the biting behaviour of Anopheles mosquitoes in the area were studied concurrently. The trial data along with costs for current recommended treatment practices were modelled to estimate the cost-effectiveness of ITNs compared with, or in addition to extending the coverage of early diagnosis and treatment services. Results: In aggregate, malaria infections, spleen rates, haemoglobin concentrations, and weight for height, did not differ significantly during the study period between villages with and without ITNs, with a weighted mean difference of −2.6 P. falciparum episodes per 1,000 weeks at risk (95% Confidence Interval −7 to 1.8). In areas with a higher incidence of malaria there was some evidence ITN protective efficacy. The economic analysis indicated that, despite the uncertainty and variability in their protective efficacy in the different study sites, ITN could still be cost-effective, but not if they displaced funding for early diagnosis and effective treatment which is substantially more cost-effective. Conclusion: In Western Myanmar deployment of ITNs did not provide consistent protection against malaria in children living in malaria endemic villages. Early diagnosis and effective treatment is a more cost effective malaria control strategy than deployment of ITNs in this area where the main vector bites early in the evening, often before people are protected by an ITN.


  • Open Access

    CMV retinitis screening and treatment in a resource‐poor setting: three‐year experience from a primary care HIV/AIDS programme in Myanmar

    by NiNi Tun, Nikolas London, Moe Kyaw Kyaw, Frank Smithuis, Nathan Ford, Todd Margolis, W Lawrence Drew, Susan Lewallen, David Heiden

    Background: Cytomegalovirus retinitis is a neglected disease in resource‐poor settings, in part because of the perceived complexity of care and because ophthalmologists are rarely accessible. In this paper, we describe a pilot programme of CMV retinitis management by non‐ophthalmologists. The programme consists of systematic screening of all high‐risk patients (CD4 3) by AIDS clinicians using indirect ophthalmoscopy, and treatment of all patients with active retinitis by intravitreal injection of ganciclovir. Prior to this programme, CMV retinitis was not routinely examined for, or treated, in Myanmar.Methods: This is a retrospective descriptive study. Between November 2006 and July 2009, 17 primary care AIDS clinicians were trained in indirect ophthalmoscopy and diagnosis of CMV retinitis; eight were also trained in intravitreal injection. Evaluation of training by a variety of methods documented high clinical competence. Systematic screening of all high‐risk patients (CD4 3) was carried out at five separate AIDS clinics throughout Myanmar.Results: A total of 891 new patients (1782 eyes) were screened in the primary area (Yangon); the majority of patients were male (64.3%), median age was 32 years, and median CD4 cell count was 38 cells/mm3. CMV retinitis was diagnosed in 24% (211/891) of these patients. Bilateral disease was present in 36% of patients. Patients with active retinitis were treated with weekly intravitreal injection of ganciclovir, with patients typically receiving five to seven injections per eye. A total of 1296 injections were administered.Conclusions: A strategy of management of CMV retinitis at the primary care level is feasible in resource‐poor settings. With appropriate training and support, CMV retinitis can be diagnosed and treated by AIDS clinicians (non‐ophthalmologists), just like other major opportunistic infections.